Vincerx Pharma Stock (NASDAQ: VINC) stock price, news, charts, stock research, profile.
Open | $0.67 |
Close | $0.68 |
Volume / Avg. | 111.81K / 257.61K |
Day Range | 0.66 - 0.70 |
52 Wk Range | 0.57 - 9.37 |
Market Cap | $20.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 1.56% |
Days to Cover | 2.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vincerx Pharma (NASDAQ:VINC) through any online brokerage.
Other companies in Vincerx Pharma’s space includes: Galecto (NASDAQ:GLTO), Evaxion Biotech (NASDAQ:EVAX), Can Fite Biofarma (AMEX:CANF), Sensei Biotherapeutics (NASDAQ:SNSE) and GlycoMimetics (NASDAQ:GLYC).
There is no analysis for Vincerx Pharma.
Vincerx Pharma has a consensus price target of $17.00.
The stock price for Vincerx Pharma (NASDAQ: VINC) is $0.7 last updated July 26, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Vincerx Pharma.
Vincerx Pharma’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Vincerx Pharma.
Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.